Trial Profile
Pharmacodynamic and pharmacokinetic properties of insulin glulisine (Apidra) in comparison to insulin lispro (Humalog) in healthy lean and obese subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin lispro
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Sanofi
- 15 Dec 2009 Actual initiation date (Apr 2004) and actual end date (Oct 2004) added as reported by ClinicalTrials.gov.
- 12 Sep 2006 New trial record.